3 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 3 |
Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults RTB101, Placebo - Covid19 | Phase 2 | Active not recruiting | Restorbio Inc. | 60 | 2020-10-13 | 2021-02-09 |
| COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation Placebo, Fisetin - Covid19 | Phase 2 | Active not recruiting | Mayo Clinic | 80 | 2020-08-03 | 2026-11-03 |
| Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes Bacillus Calmette-Guérin, Saline injection - Diabetes Mellitus, Type One, Diabetes Mellitus, Type I | Phase 2 | Active not recruiting | Massachusetts General Hospital | 150 | 2015-06-01 | 2026-04-13 |
COVID-19 (3) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 1 (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Virus Diseases (1)
Coronaviridae Infections (3) · Coronavirus Infections (3) · Infections (3) · Lung Diseases (3) · Nidovirales Infections (3) · Pneumonia (3) · Pneumonia, Viral (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (2) · Autoimmune Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1)
Sodium Chloride (1) · dactolisib (1) · fisetin (1)
Massachusetts General Hospital (1) · Mayo Clinic (1) · Restorbio Inc. (1)
United States (3)
Denise L Faustman, MD, PhD (1) · Paschalis Vergidis, MD (1)
R01AG064802 (1)